GGrantIndex
Sort

78,016 grants matching breast cancer

Targeted Discovery of Marine-derived Anticancer Leads

$1,092,108
Phil Crews · University Of California Santa Cruz · U19 · FY2008 · CA

A NOVEL DRUGGABLE EPIGENETIC VULNERABILITY PATHWAY IN BREAST CANCER

$1,091,955
University Of Alabama At Birmingham · · FY2019 · Department of the Army

CANTRANce: A tool to translate intermediate endpoints to mortality in CE studies

$1,091,952
Ruth D Etzioni · Fred Hutchinson Cancer Research Center · RC4 · FY2010 · CA

Targeted and global proteomic strategies for early breast cancer detection

$1,091,701
Susan J. Fisher · University Of California, San Francisco · U24 · FY2011 · CA

Texas Center for Minority Health, Education, Research and Outreach

$1,091,427
Jamboor K Vishwanatha · University Of North Texas Hlth Sci Ctr · U54 · FY2017 · MD

PNNL Proteome Characterization Center

$1,091,415
Tao Liu · Battelle Pacific Northwest Laboratories · U24 · FY2017 · CA

Molecular Pathogenesis of Basal-like Breast Cancer

$1,090,942
Richard J Baer · Columbia University Health Sciences · P01 · FY2013 · CA

Collaborative Protein Technology Resource - Nano-Scale Protein Analysis Section

$1,090,698
Noemi Kedei · Division Of Basic Sciences - Nci · ZIC · FY2022 · CA

High-throughput sequencing to identify novel melanoma susceptibility genes

$1,090,017
Chad Daniel Huff · University Of Tx Md Anderson Can Ctr · R01 · FY2015 · CA

A Novel Optical Spectral Imaging System for Rapid Imaging of Breast Tumor Margins

$1,089,691
Nimmi Ramanujam · Duke University · R01 · FY2012 · EB

Center of Excellence for Cancer Research, Training and Community Service

$1,089,565
Karam F.a. Soliman · Florida Agricultural And Mechanical Univ · P20 · FY2016 · MD

Integrated analyses of genetics, epigenetics, and gene expression

$1,089,132
Maxwell Lee · Division Of Basic Sciences - Nci · ZIH · FY2020 · CA

Mechanisms of the Hormonal Prevention of Breast Cancer

$1,088,976
Baylor College Of Medicine · P01 · FY2005 · CA

Multiscale Mathematical Modeling of Cancer Progression

$1,088,934
Vito Quaranta · Vanderbilt University · U54 · FY2013 · CA

National Capital Area (NCA) Minority/Underserved NCORP

$1,088,847
Lucile L Adams-Campbell · Georgetown University · UG1 · FY2020 · CA

RaceCAR-M immunotherapy for cancer and beyond

$1,088,500
Denise J. Montell · University Of California Santa Barbara · DP1 · FY2024 · CA

RaceCAR-M immunotherapy for cancer and beyond

$1,088,500
Denise J. Montell · University Of California Santa Barbara · DP1 · FY2025 · CA

DNA Sequencing

$1,088,205
Trevor K Archer · National Institute Of Environmental Health Sciences · ZIC · FY2013 · ES

Feedback, lineages and cancer: A multidisciplinary approach.

$1,086,644
John Lowengrub · University Of California-Irvine · RC2 · FY2009 · CA

New Radiopharmaceuticals and New Paradigms in Positron Emission Tomography

$1,086,464
Dale O Kiesewetter · National Institute Of Biomedical Imaging And Bioengineering · ZIA · FY2009 · EB

A RESOURCE FOR MAGNETIC RESONANCE AND OPTICAL RESEARCH

$1,086,140
University Of Pennsylvania · P41 · FY2002 · RR

Breast, Colorectal, and Ovary Cancer Clinical Validation Center

$1,085,901
Christopher I Li · Fred Hutchinson Cancer Research Center · U01 · FY2018 · CA

1/2 Partnerships to Enhance Alcohol Research across NCCU and UNC (PEAR-NC)

$1,085,760
Simon Alexander Marshall · North Carolina Central University · U54 · FY2025 · AA

Fox Chase Cancer Center CCOP-Research Base Program

$1,085,610
Fox Chase Cancer Center · U10 · FY2003 · CA

Mechanisms of Normal Tissue Toxicity

$1,085,592
Deborah Citrin · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA